These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21371650)

  • 21. [Achievement of sputum culture negative conversion by minocycline in a case with extensively drug-resistant pulmonary tuberculosis].
    Kawada H; Yamazato M; Shinozawa Y; Suzuki K; Otani S; Ouchi M; Miyairi M
    Kekkaku; 2008 Nov; 83(11):725-8. PubMed ID: 19086436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].
    Yamamoto M; Morishita M; Hirano Y; Nagata A; Yazaki M
    Kekkaku; 1974 Jul; 49(7):195-9. PubMed ID: 4214961
    [No Abstract]   [Full Text] [Related]  

  • 23. A microscopic method for the evaluation of the bacillary output in sputum of tuberculous patients under chemotherapy.
    Bercea O; Bogdănescu V; Marcian S; Ceicu A
    Scand J Respir Dis; 1969; 50(2):89-100. PubMed ID: 4898946
    [No Abstract]   [Full Text] [Related]  

  • 24. Leads from the MMWR. Bacteriologic conversion of sputum among tuberculosis patients--United States.
    JAMA; 1986 Jan 24-31; 255(4):451, 455-6. PubMed ID: 3941524
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of tuberculosis patients with massive bacterial excretion].
    Gavril'ev SS; Vinokurova MK
    Probl Tuberk; 1997; (2):17-8. PubMed ID: 9235572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of tuberculosis with controlled viability of Mycobacteria in the sputum].
    Rudoĭ NM; Erkovskaia OIu
    Probl Tuberk; 1978 May; (5):43-7. PubMed ID: 97658
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under revised national tuberculosis control programme.
    Singla R; Singla N; Sarin R; Arora VK
    Indian J Chest Dis Allied Sci; 2005; 47(1):19-23. PubMed ID: 15704711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental yield in sputum smear positivity by examining a second early morning sputum specimen in follow-up patients on DOTS: 7 year analysis of RNTCP laboratory register.
    Nataraj G; Kanade S; Parikh R; Khatri V; Mehta P; Athavale A; Arun B
    Indian J Tuberc; 2011 Apr; 58(2):60-5. PubMed ID: 21644391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sputum conversion at the end of intensive phase treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection.
    Aggarwal D; Mohapatra PR
    Indian J Med Res; 2008 Apr; 127(4):408; author reply 408-9. PubMed ID: 18577800
    [No Abstract]   [Full Text] [Related]  

  • 30. [The nature of bacterial secretions in patients with focal pulmonary tuberculosis].
    Il'ina TIa
    Probl Tuberk; 1974; (10):6-10. PubMed ID: 4213567
    [No Abstract]   [Full Text] [Related]  

  • 31. Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis.
    Farnia P; Mohammadi F; Mirsaedi M; Zarife AZ; Tabatabee J; Bahadori K; Bahadori M; Masjedi MR; Velayati AA
    J Clin Microbiol; 2004 Jul; 42(7):3324-5. PubMed ID: 15243106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The infectiousness of tuberculosis].
    Dierkesmann R
    Offentl Gesundheitswes; 1990; 52(8-9):501-5. PubMed ID: 2146566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of the Candida genus as associated flora in pulmonary tuberculosis].
    Del Rey Calero J; Casal Roman M; Martinez Alcazar P
    Rev Clin Esp; 1974 Jul; 134(2):175-80. PubMed ID: 4438723
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bacteriologic test during rifampicin treatment].
    Ivaldy F
    Rev Tuberc Pneumol (Paris); 1969; 33(6):818-20. PubMed ID: 4989191
    [No Abstract]   [Full Text] [Related]  

  • 37. Association between Mycobacterium tuberculosis lineage and time to sputum culture conversion.
    Click ES; Winston CA; Oeltmann JE; Moonan PK; Mac Kenzie WR
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):878-84. PubMed ID: 23743308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of the activity of sputum-negative pulmonary tuberculosis].
    Tu DH
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Feb; 6(1):32-4. PubMed ID: 6872771
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interrelation between the isolation of Mycobacterium tuberculosis and Candida from patients with pulmonary tuberculosis].
    Levina EL
    Probl Tuberk; 1969; 47(9):78-82. PubMed ID: 4989794
    [No Abstract]   [Full Text] [Related]  

  • 40. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?
    Badoum G; Saleri N; Dembélé MS; Ouedraogo M; Pinsi G; Boncoungou K; Bonkoungou V; Birba E; Miotto P; Migliori GB; Cirillo DM; Matteelli A
    Eur Respir J; 2011 May; 37(5):1283-5. PubMed ID: 21532018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.